Trial Profile
Phase I trial of ARRY 797 in patients with haematological malignancies.
Status:
Not stated
Phase of Trial:
Phase I
Latest Information Update: 22 Nov 2012
Price :
$35
*
At a glance
- Drugs Emprumapimod (Primary)
- Indications Haematological malignancies
- Focus Adverse reactions
- Sponsors Array BioPharma
- 13 Apr 2007 New trial record.